Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of recombinant human albumin injection in cirrhosis with ascites and hypoalbuminemia
CTR20231577Phase 3Completed
- Sponsor
- Tonghua Anrate Biopharmaceutical Co., Ltd.
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human albumin in Cirrhosis, ascites, hypoalbuminemia, sponsored by Tonghua Anrate Biopharmaceutical Co., Ltd.. Started May 2023; status: completed.
02
Drugs
recombinant human albumin
03
Conditions
Cirrhosisasciteshypoalbuminemia
Beyond the preview
Go deeper on CTR20231577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231577.